Boston startup Saphena Medical is kicking off a Series B round for its endoscopic vein harvesting device.
The startup launched last year with $3 million in Series A funding, which it said at the time was enough to push through regulatory clearance. But it’s recently raised another $1.2 million of a potential $3 million Series B round, according to a recent regulatory filing.
Saphena Medical spun out of Pavilion Medical Innovations, a sort of medical device think tank formed out of Catalyst Health Ventures.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The startups working to consolidate veinous harvesting devices into one tool – the so-called Venapax Endoscopic Vessel Harvesting System. It holds a flexible tip that stays closed during dissection, but it expands when the electrodes used in surgery are deployed. It says:
The electrodes can be easily deployed or retracted as needed during dissection. Precise control is delivered via bi-directional, circumferential rotation of electrodes. This allows for easy access to all vessel side branches because the device can be easily positioned for all orientations. Bi-polar cauterization treats tissue placed between electrodes on either side where the double-sided blade cuts tissue after cauterization.
The company’s led by Pavilion founder Michael Glennon, who is also CEO of Cruzar Medsystems, another Boston device startup that’s developing a balloon catheter meant to cross obstructive lesions.